US20210161507A1 - System and method for integrated biopsy and therapy - Google Patents
System and method for integrated biopsy and therapy Download PDFInfo
- Publication number
- US20210161507A1 US20210161507A1 US17/176,218 US202117176218A US2021161507A1 US 20210161507 A1 US20210161507 A1 US 20210161507A1 US 202117176218 A US202117176218 A US 202117176218A US 2021161507 A1 US2021161507 A1 US 2021161507A1
- Authority
- US
- United States
- Prior art keywords
- biopsy
- images
- mri
- technology
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001574 biopsy Methods 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000002560 therapeutic procedure Methods 0.000 title description 39
- 238000011282 treatment Methods 0.000 claims abstract description 26
- 238000005516 engineering process Methods 0.000 claims abstract description 25
- 238000003745 diagnosis Methods 0.000 claims abstract description 13
- 238000003384 imaging method Methods 0.000 claims abstract description 10
- 210000001835 viscera Anatomy 0.000 claims abstract description 4
- 230000008685 targeting Effects 0.000 claims abstract description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 60
- 238000002604 ultrasonography Methods 0.000 description 32
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 17
- 206010060862 Prostate cancer Diseases 0.000 description 16
- 230000004927 fusion Effects 0.000 description 15
- 210000002307 prostate Anatomy 0.000 description 15
- 239000000523 sample Substances 0.000 description 13
- 238000012545 processing Methods 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 8
- 230000015654 memory Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007170 pathology Effects 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002600 positron emission tomography Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010317 ablation therapy Methods 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
- A61B6/5247—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image combining images from an ionising-radiation diagnostic technique and a non-ionising radiation diagnostic technique, e.g. X-ray and ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/52—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/5215—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data
- A61B8/5238—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data for combining image data of patient, e.g. merging several images from different acquisition modes into one image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/374—NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/12—Arrangements for detecting or locating foreign bodies
Definitions
- This disclosure relates to imaging technology, and more particularly to systems and methods that integrate biopsy imaging with therapeutic procedures.
- Prostate cancer affects one in every six men in the western world at some point in their lives. Because of the lack of imaging and image guidance, conventional (blind) sextant biopsy used for diagnosis is painful and unreliable. As a result, prostate cancer is over-diagnosed and over-treated. In therapy, almost all prostate cancers are currently treated by surgery or whole-prostate radiation therapy, leading to significant side effects.
- a biopsy is ultrasound guided because ultrasound is real-time and cost-effective and can be employed to visualize the prostate.
- ultrasound does not show a cancer. So, instead of going for the cancer in a targeted, image-guided way, the biopsy is blindly sampled with a sextant biopsy, which results in an up to a 30% false negative rate.
- image guidance also extends to prostate cancer therapy. Without adequate guidance, therapy approaches remain limited to whole-gland therapy, which shows significant side effects such as urinary incontinence and impotence in a large number of patients. Therefore, a move away from blind and whole-gland approaches needs to be made.
- Magnetic resonance imaging is currently the most promising imaging modality for depicting prostate cancer and other abnormalities and cancers on internal organs.
- Magnetic resonance imaging (MRI) guidance is not compatible with current workflows, however. Since MRI is expensive and typically not used for procedure guidance, it is desirable to fuse pre-operative MRI with real-time transrectal ultrasound (TRUS) during an intervention related to the prostate. As a result, the MRI information can be used during the intervention outside the MRI suite.
- TRUS transrectal ultrasound
- the present inventors developed an image fusion system for MRI/TRUS guided targeted biopsy.
- the fusion system utilized electromagnetic (EM) tracking for spatial localization of an ultrasound probe. Spatial tracking of the probe is enabled by attaching a biopsy guide to the probe that is customized with electromagnetic tracking sensors.
- EM electromagnetic
- a sextant biopsy employs a targeted biopsy to increase the yield of the sextant biopsy and detect lesions that are not recognizable by MRI.
- prostate biopsy and therapy are two separate procedures. Therefore, even if lesions are found in the sextant biopsy procedure, it is difficult to go back exactly to the same location during the therapy to treat the lesion.
- the position information of sextant biopsy is under-utilized. With the tracked biopsy and image fusion, the gap between prostate biopsy and focal therapy can be bridged by using the same diagnosis MRI image to document biopsy, plan for therapy and provide image guidance.
- An integrated prostate cancer suite in accordance with the present principles enables physicians to seamlessly plan, navigate, execute and monitor a biopsy or focal therapy procedure. It is based on the fusion of pre-acquired MRI with live transrectal ultrasound (TRUS): target information from MRI augments TRUS guidance, which improves the accuracy of biopsy and focal treatment.
- TRUS live transrectal ultrasound
- a system and method combine biopsy and therapy by using a same diagnostic MRI image to document biopsy, plan for therapy and provide image guidance.
- the system/method includes the following: (1) performing tracked sextant with MRI-targeted biopsies for prostate cancer detection, (2) identifying all the biopsy sites on MRI using MRI/TRUS fusion, (3) planning focal therapy on the MRI image using the pathology results of the biopsy specimens, and (4) fusing the MRI-based treatment plan with real-time TRUS for focal therapy guidance.
- Combining sextant biopsy with targeted biopsy increases the yield of sextant biopsy and detects lesions that are not recognizable by MRI.
- Prostate biopsy and therapy can be carried out at different times, but the biopsy findings are used to guide the therapy.
- the system and method are adaptable and not limited to treatment of prostate cancer.
- a system and method for integrating diagnosis and treatment for internal tissues includes imaging at least a portion of an internal organ of a subject using a first technology capable of differentiating tissue types, and targeting and accessing biopsy sites using images of the first technology fused with images of a second technology capable of real-time image updates.
- Treatment of a biopsy site is planned using the images of the first technology.
- Target information that may be used for treatment planning includes positive biopsy locations and/or suspicious regions of diagnostic images (e.g. MRI or MRI+PET fusion). Instruments for treating the biopsy site are guided by fusing the images of the first technology with the images of the second technology.
- FIG. 1 is a block diagram showing a system and method for integrating diagnosis and treatment for internal tissues in accordance with the present principles
- FIG. 2 is a block/flow diagram showing a system/method for integrating diagnosis and treatment for internal tissues in accordance with the present principles
- FIGS. 3A-3C are MRI images showing three views of a specimen employed in accordance with an illustrative procedure.
- FIG. 3D is a fused image combining an MRI with and ultrasound image in accordance with an illustrative embodiment.
- the present disclosure describes systems and methods for fusing imaging technologies and employing biopsy information in therapy or subsequent procedures.
- the present embodiments will be illustratively described in terms of prostate cancer diagnosis and therapy. It should be understood that the present principles may be employed for other cancers or procedures and should not be construed as limited by the illustrative examples.
- MRI imaging and MRI/ultrasound fusion technologies are employed to enable lesion targeted biopsy and focal therapy which may reduce side effects. (E.g., conventional prostate cancer biopsy and therapy are blind, whole-gland procedures with significant side effects).
- a method in accordance with one embodiment includes performing a tracked sextant with MRI-targeted biopsies for prostate cancer detection; identifying all the biopsy sites on the MRI using MRI/TRUS fusion; planning focal therapy on the MRI image using the pathology results of the biopsy specimens and fusing the MRI-based treatment plan with real-time TRUS for focal therapy guidance. This method bridges the gap between prostate biopsy and therapy, increases the yield of biopsy and reduces the side effects of therapy.
- FIGS. may be implemented in various combinations of hardware and/or software and provide functions which may be combined in a single element or multiple elements.
- the present principles can take the form of a computer program product accessible from a computer-usable or computer-readable medium providing program code for use by or in connection with a computer or any instruction execution system.
- a computer-usable or computer readable medium can be any apparatus that may include, store, communicate, propagate, or transport the program for use by or in connection with the instruction execution system, apparatus, or device.
- the medium can be an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system (or apparatus or device).
- Examples of a computer-readable medium include a semiconductor or solid state memory, magnetic tape, a removable computer diskette, a random access memory (RAM), a read-only memory (ROM), a rigid magnetic disk and an optical disk. Current examples of optical disks include compact disk-read only memory (CD-ROM), compact disk-read/write (CD-R/W) and DVD.
- a data processing system suitable for storing and/or executing program code may include at least one processor coupled directly or indirectly to memory elements through a system bus.
- the processor or processing system may be provided with the scope system or provided independently of the scope system.
- the memory elements can include local memory employed during actual execution of the program code, bulk storage, and cache memories which provide temporary storage of at least some program code to reduce the number of times code is retrieved from bulk storage during execution.
- I/O devices including but not limited to keyboards, displays, pointing devices, etc. may be coupled to the system either directly or through intervening I/O controllers.
- Network adapters may also be coupled to the system to enable the data processing system to become coupled to other data processing systems or remote printers or storage devices through intervening private or public networks.
- Modems, cable modem and Ethernet cards are just a few of the currently available types of network adapters.
- System 100 includes a tracking system 102 employed during an ultrasound-guided medical procedure.
- the tracking system 102 may include, e.g., an electromagnetic tracking system with a field generator placed near a patient or subject 107 to provide positional coordinates of a tracking sensor(s) 106 during a procedure.
- the tracking sensor 106 is attached to an ultrasound probe 108 .
- a needle guide 110 may be provided with tracking sensors 106 which can be attached to the ultrasound probe 108 .
- the tracking sensor 106 may be attached to a biopsy needle 112 .
- the equipment and methodology may be varied in accordance with the procedure and anatomy being analyzed and treated.
- a processing unit 116 is connected to the tracking system 102 and an ultrasound scanner 118 (or other real-time scanning technology).
- the processing unit 116 simultaneously obtains ultrasound images from the scanner 118 , and corresponding position information from the sensor 106 .
- the processing unit 116 can be a workstation, or may be part of the ultrasound scanner 118 .
- the processing unit 116 includes memory 121 which includes a software program 120 for execution on the processing unit 116 that guides an MRI-targeted biopsy, acquires and stores real-time ultrasound images, together with the volume's tracking system coordinates provided by the sensor 106 , identifies the needle 110 or other interventional device in real-time or recorded ultrasound, and transforms the biopsy sample's position to a corresponding spot in an MRI image 119 .
- Processing unit 116 includes software 123 for focal therapy planning based on the MRI image 119 , the biopsy positions in the MRI image 119 and pathology results of the biopsies.
- An image guidance system 122 executes on processing unit 116 for focal therapy that permits fusing a treatment plan with real-time ultrasonic imaging, and guiding targeted focal therapy based on the plan.
- the image guidance system 122 of the biopsy can be adapted for focal therapy, or the image guidance system 122 for focal therapy can be based on mechanical devices 124 with position encoders and template grids. Such mechanical devices can therefore be accurately tracked with reference to image positions obtained in real-time and fused with other images (e.g., MRI).
- the MRI images and the scanner images are combined or fused using device tracking (e.g., the ultrasound probe, a registration pointer etc.) and/or image registration.
- device tracking e.g., the ultrasound probe, a registration pointer etc.
- image registration e.g., the image registration
- real-time images e.g., ultrasound images
- the information is advantageously employed for both diagnosis and for treatment, and the fused image can be updated in real-time to track diagnosis, analysis and treatment.
- Scanned and fused images may be viewed using one or more display devices 130 , which provide visual feedback for users to interface with the system 100 .
- a block/flow diagram illustratively depicts a system/method for diagnosis (e.g., biopsy) and treatment (e.g., focal therapy) for a surgical procedure.
- the system/method combines a tracked sextant and MRI-targeted biopsies for prostate cancer detection.
- images are collected for a subject.
- the images preferably employ a technology capable of differentiating between tissues (e.g., MRI technology).
- static (e.g., MRI or other technology) images are fused with real-time updated images (e.g., ultrasonic images) by performing a registration method or by employing tracked coordinate systems.
- all the biopsy sites are identified on the MRI using MRI/TRUS fusion.
- the biopsy site(s) is targeted and samples are obtained using guided interventional instruments in block 206 .
- Positional information for the biopsy site(s) is recorded and stored for use later in therapy/treatment.
- the MRI image is then used to plan for focal therapy based on a pathology examination of the biopsy specimens in block 207 .
- the plan (static image) is fused with real-time images (e.g., TRUS) to guide focal therapy in block 208 .
- the plan is carried out or executed using the MRI and TRUS information in the fused image in block 210 .
- MRI-targeted biopsy The prostate MR image is acquired first and transferred to a workstation (e.g., 116 , FIG. 1 ). The patient is then positioned on an examination table and a 2D TRUS probe with tracking sensors is inserted into the rectum. At the beginning of the TRUS procedure, the operator performs a 2D axial sweep (prostate base to apex) such that the series of 2D ultrasound images covers the entire volume of the prostate. (In an alternative, a 3D ultrasound probe can be used to obtain the prostate volume.) The images and corresponding tracking data from the tracking sensors are transferred to the workstation in real-time. Based on these images and tracking data, a volumetric ultrasound image is immediately reconstructed on the workstation.
- a workstation e.g., 116 , FIG. 1
- the patient is then positioned on an examination table and a 2D TRUS probe with tracking sensors is inserted into the rectum.
- the operator performs a 2D axial sweep (prostate base to apex
- the MR image and ultrasound volume are then spatially aligned.
- the operator manually holds the 2D probe to scan the prostate.
- Spatial tracking of the ultrasound probe, and registering MRI coordinate system with the tracking coordinate system enables real-time fusion of the live ultrasound image with the spatially corresponding multi-planar reconstruction (MPR) from the MRI scan.
- MPR multi-planar reconstruction
- a tissue sample may be obtained when the needle is aligned with the target.
- Tracked sextant biopsy can be carried out with a targeted biopsy under the same clinical setup. The order between them is not important. The physician can ignore the MRI image and perform sextant biopsy under TRUS guidance only. The TRUS images and the corresponding tracking information of the probe can be recorded. The locations of sextant biopsy can be (retrospectively) identified on the MRI using MRI/TRUS fusion as shown in FIGS. 3A-3D .
- FIGS. 3A-3D images of a prostate region in a subject are illustratively depicted.
- FIGS. 3A-3D show the development of an MRI/TRUS fusion for a biopsy needle firing.
- FIG. 3D shows an alpha-blending of MRI and TRUS images. This fusion provides the accuracy needed for identifying particular tissues along with the dynamic and real-time images provided by ultrasound.
- FIGS. 3A-3C show axial, sagittal and coronal views, respectively, of an MRI focused on a mid-point of a specimen to be analyzed and treated in a patient.
- Markers 302 , 304 and 306 show two end points ( 302 and 306 ) and a mid-point ( 304 ) of the biopsy specimen. The markers 302 , 304 and 306 indicate a biopsy needle trajectory.
- CT computed tomography
- PET positron emission tomography
- SPECT single photon emission computer tomography
- 3D ultrasound 3D ultrasound
- cancer probability mapping 3D ultrasound
- image fusion of multiple diagnostic images such as MRI, PET and contrast ultrasound, etc.
- electromagnetic tracking optical, mechanical or other tracking systems may be employed.
- the locations of sextant and targeted biopsies can be correlated with the pathology examination of the specimens collected during the biopsy.
- a treatment plan can be made on the MRI image to cover all the cancer locations and spare the healthy tissue. Both positive and negative biopsy cores can be used to plan focal therapy.
- the sites of the sextant biopsy can be optimized based on the MRI target locations to maximize the probability for finding cancer.
- the processes described may be applied to ultrasound/MR images of the breast, liver, kidney or other soft-tissue targets.
- the workflow of focal therapy is similar to that of the MRI-targeted biopsy. Instead of using the MRI targets, the treatment plan can be highlighted on real-time TRUS for procedure guidance.
- the therapy modality can be any modality suitable for focal therapy, such as cryo-ablation, radiofrequency ablation or other ablative therapies, brachytherapy or other radiation-based therapy, or photodynamic therapy.
- the treatment delivery locations can be tracked and recorded as well with the same tracking system used to track biopsy locations.
- the system can then also be used for optimizing multiple, sequential treatments over time, by considering prior treated regions in the treatment plan for subsequent/repeat treatments (e.g., avoiding unnecessary duplication of treatment in the same area).
- electronic images may be colorized or otherwise marked to identify treated regions or regions yet to be treated or both. Other manipulations of images data are also contemplated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- High Energy & Nuclear Physics (AREA)
- Optics & Photonics (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Surgical Instruments (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Radiation-Therapy Devices (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
A system and method for integrating diagnosis and treatment for internal tissues includes imaging at least a portion of an internal organ of a subject using a first technology capable of differentiating tissue types, and targeting and accessing biopsy sites using images of the first technology fused with images of a second technology capable of real-time image updates. Treatment of a biopsy site is planned using the images of the first technology. Instruments for treating the biopsy site are guided by fusing the images of the first technology with the images of the second technology.
Description
- This application is a continuation of U.S. application Ser. No. 13/321,836, filed Nov. 22, 2011, which is a national stage entry of PCT/IB2010/052152 filed May 14, 2010 (WO 2010/140075), which claims priority to provisional application Ser. No. 61/184,322, filed Jun. 5, 2009, all incorporated herein by reference.
- This invention was made in the performance of a Cooperative Research and Development Agreement with the United States Public Health Service (CRADA No. NCI-NIHCC-01864). The Government of the United States has certain rights in the invention.
- This disclosure relates to imaging technology, and more particularly to systems and methods that integrate biopsy imaging with therapeutic procedures.
- Prostate cancer affects one in every six men in the western world at some point in their lives. Because of the lack of imaging and image guidance, conventional (blind) sextant biopsy used for diagnosis is painful and unreliable. As a result, prostate cancer is over-diagnosed and over-treated. In therapy, almost all prostate cancers are currently treated by surgery or whole-prostate radiation therapy, leading to significant side effects.
- Today, prostate cancer care is performed without ample visual feedback. A biopsy is ultrasound guided because ultrasound is real-time and cost-effective and can be employed to visualize the prostate. Unfortunately, ultrasound does not show a cancer. So, instead of going for the cancer in a targeted, image-guided way, the biopsy is blindly sampled with a sextant biopsy, which results in an up to a 30% false negative rate. One problem with image guidance also extends to prostate cancer therapy. Without adequate guidance, therapy approaches remain limited to whole-gland therapy, which shows significant side effects such as urinary incontinence and impotence in a large number of patients. Therefore, a move away from blind and whole-gland approaches needs to be made.
- In accordance with the present principles, a move toward targeted, localized procedures is made. Magnetic resonance imaging (MRI) is currently the most promising imaging modality for depicting prostate cancer and other abnormalities and cancers on internal organs. Magnetic resonance imaging (MRI) guidance is not compatible with current workflows, however. Since MRI is expensive and typically not used for procedure guidance, it is desirable to fuse pre-operative MRI with real-time transrectal ultrasound (TRUS) during an intervention related to the prostate. As a result, the MRI information can be used during the intervention outside the MRI suite. In a previous work, the present inventors developed an image fusion system for MRI/TRUS guided targeted biopsy. The fusion system utilized electromagnetic (EM) tracking for spatial localization of an ultrasound probe. Spatial tracking of the probe is enabled by attaching a biopsy guide to the probe that is customized with electromagnetic tracking sensors.
- Although MRI has good sensitivity and specificity in prostate cancer diagnosis, it may not be sufficiently definitive. MRI may miss identifying prostate lesions, suggesting that MRI-targeted prostate biopsy alone may be insufficient. In accordance with the present embodiments, a sextant biopsy employs a targeted biopsy to increase the yield of the sextant biopsy and detect lesions that are not recognizable by MRI.
- In the current standard care of prostate cancer, prostate biopsy and therapy are two separate procedures. Therefore, even if lesions are found in the sextant biopsy procedure, it is difficult to go back exactly to the same location during the therapy to treat the lesion. The position information of sextant biopsy is under-utilized. With the tracked biopsy and image fusion, the gap between prostate biopsy and focal therapy can be bridged by using the same diagnosis MRI image to document biopsy, plan for therapy and provide image guidance.
- An integrated prostate cancer suite in accordance with the present principles enables physicians to seamlessly plan, navigate, execute and monitor a biopsy or focal therapy procedure. It is based on the fusion of pre-acquired MRI with live transrectal ultrasound (TRUS): target information from MRI augments TRUS guidance, which improves the accuracy of biopsy and focal treatment.
- A system and method combine biopsy and therapy by using a same diagnostic MRI image to document biopsy, plan for therapy and provide image guidance. In one embodiment, the system/method includes the following: (1) performing tracked sextant with MRI-targeted biopsies for prostate cancer detection, (2) identifying all the biopsy sites on MRI using MRI/TRUS fusion, (3) planning focal therapy on the MRI image using the pathology results of the biopsy specimens, and (4) fusing the MRI-based treatment plan with real-time TRUS for focal therapy guidance. Combining sextant biopsy with targeted biopsy increases the yield of sextant biopsy and detects lesions that are not recognizable by MRI. Prostate biopsy and therapy can be carried out at different times, but the biopsy findings are used to guide the therapy. The system and method are adaptable and not limited to treatment of prostate cancer.
- A system and method for integrating diagnosis and treatment for internal tissues includes imaging at least a portion of an internal organ of a subject using a first technology capable of differentiating tissue types, and targeting and accessing biopsy sites using images of the first technology fused with images of a second technology capable of real-time image updates. Treatment of a biopsy site is planned using the images of the first technology. Target information that may be used for treatment planning includes positive biopsy locations and/or suspicious regions of diagnostic images (e.g. MRI or MRI+PET fusion). Instruments for treating the biopsy site are guided by fusing the images of the first technology with the images of the second technology.
- These and other objects, features and advantages of the present disclosure will become apparent from the following detailed description of illustrative embodiments thereof, which is to be read in connection with the accompanying drawings.
- This disclosure will present in detail the following description of preferred embodiments with reference to the following figures wherein:
-
FIG. 1 is a block diagram showing a system and method for integrating diagnosis and treatment for internal tissues in accordance with the present principles; -
FIG. 2 is a block/flow diagram showing a system/method for integrating diagnosis and treatment for internal tissues in accordance with the present principles; -
FIGS. 3A-3C are MRI images showing three views of a specimen employed in accordance with an illustrative procedure; and -
FIG. 3D is a fused image combining an MRI with and ultrasound image in accordance with an illustrative embodiment. - The present disclosure describes systems and methods for fusing imaging technologies and employing biopsy information in therapy or subsequent procedures. The present embodiments will be illustratively described in terms of prostate cancer diagnosis and therapy. It should be understood that the present principles may be employed for other cancers or procedures and should not be construed as limited by the illustrative examples. In one particularly useful application, MRI imaging and MRI/ultrasound fusion technologies are employed to enable lesion targeted biopsy and focal therapy which may reduce side effects. (E.g., conventional prostate cancer biopsy and therapy are blind, whole-gland procedures with significant side effects).
- MRI is insufficient to detect all prostate cancer. To improve the outcome of the procedures, a method in accordance with one embodiment includes performing a tracked sextant with MRI-targeted biopsies for prostate cancer detection; identifying all the biopsy sites on the MRI using MRI/TRUS fusion; planning focal therapy on the MRI image using the pathology results of the biopsy specimens and fusing the MRI-based treatment plan with real-time TRUS for focal therapy guidance. This method bridges the gap between prostate biopsy and therapy, increases the yield of biopsy and reduces the side effects of therapy.
- It should be understood that the present disclosure is applicable for any cancer or disease in any organism. The elements depicted in the FIGS. may be implemented in various combinations of hardware and/or software and provide functions which may be combined in a single element or multiple elements.
- Furthermore, the present principles can take the form of a computer program product accessible from a computer-usable or computer-readable medium providing program code for use by or in connection with a computer or any instruction execution system. A computer-usable or computer readable medium can be any apparatus that may include, store, communicate, propagate, or transport the program for use by or in connection with the instruction execution system, apparatus, or device. The medium can be an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system (or apparatus or device). Examples of a computer-readable medium include a semiconductor or solid state memory, magnetic tape, a removable computer diskette, a random access memory (RAM), a read-only memory (ROM), a rigid magnetic disk and an optical disk. Current examples of optical disks include compact disk-read only memory (CD-ROM), compact disk-read/write (CD-R/W) and DVD.
- A data processing system suitable for storing and/or executing program code may include at least one processor coupled directly or indirectly to memory elements through a system bus. The processor or processing system may be provided with the scope system or provided independently of the scope system. The memory elements can include local memory employed during actual execution of the program code, bulk storage, and cache memories which provide temporary storage of at least some program code to reduce the number of times code is retrieved from bulk storage during execution. Input/output or I/O devices (including but not limited to keyboards, displays, pointing devices, etc.) may be coupled to the system either directly or through intervening I/O controllers.
- Network adapters may also be coupled to the system to enable the data processing system to become coupled to other data processing systems or remote printers or storage devices through intervening private or public networks. Modems, cable modem and Ethernet cards are just a few of the currently available types of network adapters.
- Referring now to the drawings in which like numerals represent the same or similar elements and initially to
FIG. 1 , asystem 100 is depicted for combining biopsy information with therapy.System 100 includes atracking system 102 employed during an ultrasound-guided medical procedure. Thetracking system 102 may include, e.g., an electromagnetic tracking system with a field generator placed near a patient or subject 107 to provide positional coordinates of a tracking sensor(s) 106 during a procedure. In one embodiment, the trackingsensor 106 is attached to anultrasound probe 108. Alternatively, aneedle guide 110 may be provided with trackingsensors 106 which can be attached to theultrasound probe 108. Optionally, the trackingsensor 106 may be attached to abiopsy needle 112. The equipment and methodology may be varied in accordance with the procedure and anatomy being analyzed and treated. - A
processing unit 116 is connected to thetracking system 102 and an ultrasound scanner 118 (or other real-time scanning technology). Theprocessing unit 116 simultaneously obtains ultrasound images from thescanner 118, and corresponding position information from thesensor 106. Theprocessing unit 116 can be a workstation, or may be part of theultrasound scanner 118. Theprocessing unit 116 includesmemory 121 which includes asoftware program 120 for execution on theprocessing unit 116 that guides an MRI-targeted biopsy, acquires and stores real-time ultrasound images, together with the volume's tracking system coordinates provided by thesensor 106, identifies theneedle 110 or other interventional device in real-time or recorded ultrasound, and transforms the biopsy sample's position to a corresponding spot in anMRI image 119.Processing unit 116 includessoftware 123 for focal therapy planning based on theMRI image 119, the biopsy positions in theMRI image 119 and pathology results of the biopsies. - An
image guidance system 122 executes onprocessing unit 116 for focal therapy that permits fusing a treatment plan with real-time ultrasonic imaging, and guiding targeted focal therapy based on the plan. Optionally, theimage guidance system 122 of the biopsy can be adapted for focal therapy, or theimage guidance system 122 for focal therapy can be based onmechanical devices 124 with position encoders and template grids. Such mechanical devices can therefore be accurately tracked with reference to image positions obtained in real-time and fused with other images (e.g., MRI). - Advantageously, the MRI images and the scanner images (e.g., ultrasonic images) are combined or fused using device tracking (e.g., the ultrasound probe, a registration pointer etc.) and/or image registration. Once registered, real-time images (e.g., ultrasound images) may benefit from the detailed MRI images (or other type images) since the fused images provide a complete set of information. The information is advantageously employed for both diagnosis and for treatment, and the fused image can be updated in real-time to track diagnosis, analysis and treatment. Scanned and fused images may be viewed using one or
more display devices 130, which provide visual feedback for users to interface with thesystem 100. - Referring to
FIG. 2 , a block/flow diagram illustratively depicts a system/method for diagnosis (e.g., biopsy) and treatment (e.g., focal therapy) for a surgical procedure. In the present example for prostate cancer, the system/method combines a tracked sextant and MRI-targeted biopsies for prostate cancer detection. Inblock 202, images are collected for a subject. The images preferably employ a technology capable of differentiating between tissues (e.g., MRI technology). Inblock 204, static (e.g., MRI or other technology) images are fused with real-time updated images (e.g., ultrasonic images) by performing a registration method or by employing tracked coordinate systems. Inblock 205, all the biopsy sites are identified on the MRI using MRI/TRUS fusion. The biopsy site(s) is targeted and samples are obtained using guided interventional instruments inblock 206. Positional information for the biopsy site(s) is recorded and stored for use later in therapy/treatment. - The MRI image is then used to plan for focal therapy based on a pathology examination of the biopsy specimens in
block 207. The plan (static image) is fused with real-time images (e.g., TRUS) to guide focal therapy inblock 208. The plan is carried out or executed using the MRI and TRUS information in the fused image inblock 210. - MRI-targeted biopsy: The prostate MR image is acquired first and transferred to a workstation (e.g., 116,
FIG. 1 ). The patient is then positioned on an examination table and a 2D TRUS probe with tracking sensors is inserted into the rectum. At the beginning of the TRUS procedure, the operator performs a 2D axial sweep (prostate base to apex) such that the series of 2D ultrasound images covers the entire volume of the prostate. (In an alternative, a 3D ultrasound probe can be used to obtain the prostate volume.) The images and corresponding tracking data from the tracking sensors are transferred to the workstation in real-time. Based on these images and tracking data, a volumetric ultrasound image is immediately reconstructed on the workstation. The MR image and ultrasound volume are then spatially aligned. During the procedure, the operator manually holds the 2D probe to scan the prostate. Spatial tracking of the ultrasound probe, and registering MRI coordinate system with the tracking coordinate system, enables real-time fusion of the live ultrasound image with the spatially corresponding multi-planar reconstruction (MPR) from the MRI scan. - When prostate motion results in misalignment between the ultrasound and MR images, image-based registration between the real-time 2D ultrasound images and the static ultrasound volume will be carried out to recover the correct MRI/TRUS fusion. A tissue sample may be obtained when the needle is aligned with the target.
- Tracked sextant biopsy: Tracked sextant biopsy can be carried out with a targeted biopsy under the same clinical setup. The order between them is not important. The physician can ignore the MRI image and perform sextant biopsy under TRUS guidance only. The TRUS images and the corresponding tracking information of the probe can be recorded. The locations of sextant biopsy can be (retrospectively) identified on the MRI using MRI/TRUS fusion as shown in
FIGS. 3A-3D . - Referring to
FIGS. 3A-3D , images of a prostate region in a subject are illustratively depicted.FIGS. 3A-3D show the development of an MRI/TRUS fusion for a biopsy needle firing.FIG. 3D shows an alpha-blending of MRI and TRUS images. This fusion provides the accuracy needed for identifying particular tissues along with the dynamic and real-time images provided by ultrasound.FIGS. 3A-3C show axial, sagittal and coronal views, respectively, of an MRI focused on a mid-point of a specimen to be analyzed and treated in a patient.Markers markers - While MRI images are described, instead of using an MRI volume for diagnosis, procedure guidance and treatment planning, other 3D (or 4D) image volumes may be employed (e.g., computed tomography (CT), positron emission tomography (PET), single photon emission computer tomography (SPECT), 3D ultrasound, and cancer probability mapping, and image fusion of multiple diagnostic images such as MRI, PET and contrast ultrasound, etc.). Further, instead of using electromagnetic tracking, optical, mechanical or other tracking systems may be employed.
- After the locations of sextant and targeted biopsies are identified on the MRI images, the locations can be correlated with the pathology examination of the specimens collected during the biopsy. A treatment plan can be made on the MRI image to cover all the cancer locations and spare the healthy tissue. Both positive and negative biopsy cores can be used to plan focal therapy. In other embodiments, instead of performing separate sextant and MRI-targeted biopsies, the sites of the sextant biopsy can be optimized based on the MRI target locations to maximize the probability for finding cancer. The processes described may be applied to ultrasound/MR images of the breast, liver, kidney or other soft-tissue targets.
- The workflow of focal therapy is similar to that of the MRI-targeted biopsy. Instead of using the MRI targets, the treatment plan can be highlighted on real-time TRUS for procedure guidance. The therapy modality can be any modality suitable for focal therapy, such as cryo-ablation, radiofrequency ablation or other ablative therapies, brachytherapy or other radiation-based therapy, or photodynamic therapy.
- Advantageously, results from several biopsies—even obtained on different times/dates—can be combined by registering a reconstructed ultrasound volume obtained for each biopsy with the same baseline MRI scan, or by registering the ultrasound sweeps with different MRI scans which in turn are spatially co-registered. The treatment delivery locations can be tracked and recorded as well with the same tracking system used to track biopsy locations. The system can then also be used for optimizing multiple, sequential treatments over time, by considering prior treated regions in the treatment plan for subsequent/repeat treatments (e.g., avoiding unnecessary duplication of treatment in the same area). In one embodiment, electronic images may be colorized or otherwise marked to identify treated regions or regions yet to be treated or both. Other manipulations of images data are also contemplated.
- In interpreting the appended claims, it should be understood that:
- a) the word “comprising” does not exclude the presence of other elements or acts than those listed in a given claim;
- b) the word “a” or “an” preceding an element does not exclude the presence of a plurality of such elements;
- c) any reference signs in the claims do not limit their scope;
- d) several “means” may be represented by the same item or hardware or software implemented structure or function; and
- e) no specific sequence of acts is intended to be required unless specifically indicated.
- Having described preferred embodiments for systems and methods (which are intended to be illustrative and not limiting), it is noted that modifications and variations can be made by persons skilled in the art in light of the above teachings. It is therefore to be understood that changes may be made in the particular embodiments of the disclosure disclosed which are within the scope and spirit of the embodiments disclosed herein as outlined by the appended claims. Having thus described the details and particularity required by the patent laws, what is claimed and desired protected by Letters Patent is set forth in the appended claims.
Claims (1)
1. A method for integrating diagnosis and treatment for internal tissues, comprising:
imaging at least a portion of an internal organ of a subject using a first technology capable of differentiating tissue types;
targeting and accessing biopsy sites using images of the first technology fused with images of a second technology capable of real-time image updates;
planning treatment of at least one of the biopsy sites using the images of the first technology; and
guiding instruments for treating the at least one biopsy site by fusing the images of the first technology with the images of the second technology.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/176,218 US20210161507A1 (en) | 2009-06-05 | 2021-02-16 | System and method for integrated biopsy and therapy |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18432209P | 2009-06-05 | 2009-06-05 | |
US201113321836A | 2011-11-22 | 2011-11-22 | |
PCT/IB2020/052152 WO2020183388A1 (en) | 2019-03-13 | 2020-03-11 | Pharmaceutical composition |
US17/176,218 US20210161507A1 (en) | 2009-06-05 | 2021-02-16 | System and method for integrated biopsy and therapy |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/321,836 Continuation US10980508B2 (en) | 2009-06-05 | 2010-05-14 | System and method for integrated biopsy and therapy |
PCT/IB2020/052152 Continuation WO2020183388A1 (en) | 2009-06-05 | 2020-03-11 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210161507A1 true US20210161507A1 (en) | 2021-06-03 |
Family
ID=42990318
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/321,836 Active 2032-10-07 US10980508B2 (en) | 2009-06-05 | 2010-05-14 | System and method for integrated biopsy and therapy |
US17/176,218 Pending US20210161507A1 (en) | 2009-06-05 | 2021-02-16 | System and method for integrated biopsy and therapy |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/321,836 Active 2032-10-07 US10980508B2 (en) | 2009-06-05 | 2010-05-14 | System and method for integrated biopsy and therapy |
Country Status (7)
Country | Link |
---|---|
US (2) | US10980508B2 (en) |
EP (1) | EP2437661B1 (en) |
JP (1) | JP5587993B2 (en) |
CN (1) | CN102481115B (en) |
BR (1) | BRPI1009004A2 (en) |
RU (1) | RU2558521C2 (en) |
WO (1) | WO2010140075A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006119431A2 (en) | 2005-04-29 | 2006-11-09 | The Regents Of The University Of Colorado, A Body Corporate | Electromagnetic characterization of tissue |
US20120083653A1 (en) * | 2010-10-04 | 2012-04-05 | Sperling Daniel P | Guided procedural treatment device and method |
JP5822554B2 (en) * | 2011-06-17 | 2015-11-24 | キヤノン株式会社 | Image processing apparatus, image processing method, photographing system, and program |
US9119550B2 (en) * | 2012-03-30 | 2015-09-01 | Siemens Medical Solutions Usa, Inc. | Magnetic resonance and ultrasound parametric image fusion |
US20130310680A1 (en) | 2012-05-21 | 2013-11-21 | The Regents Of The University Of Colorado, A Body Corporate | Three-dimensional optical imaging and therapy of prostate cancer |
US9814448B2 (en) | 2012-05-21 | 2017-11-14 | Precision Biopsy, Inc. | Three-dimensional optical imaging and therapy of prostate cancer |
US20130316318A1 (en) * | 2012-05-22 | 2013-11-28 | Vivant Medical, Inc. | Treatment Planning System |
US20140188440A1 (en) | 2012-12-31 | 2014-07-03 | Intuitive Surgical Operations, Inc. | Systems And Methods For Interventional Procedure Planning |
CN104936546B (en) * | 2013-01-17 | 2016-09-14 | 皇家飞利浦有限公司 | In the medical of ultrasonic guidance, regulate the method for focal zone and use the system of described method |
WO2014141262A1 (en) * | 2013-03-15 | 2014-09-18 | Uc-Care Ltd. | System and methods for processing a biopsy sample |
WO2014170144A1 (en) | 2013-04-05 | 2014-10-23 | Koninklijke Philips N.V. | Energy deposition zone determination for a catheter with an ultrasound array |
KR101563498B1 (en) * | 2013-05-02 | 2015-10-27 | 삼성메디슨 주식회사 | Ultrasound system and method for providing change information of target object |
EP3013244B1 (en) * | 2013-06-26 | 2019-01-16 | Koninklijke Philips N.V. | System and method for mapping ultrasound shear wave elastography measurements |
WO2017123981A1 (en) | 2016-01-15 | 2017-07-20 | Rfemb Holdings, Llc | Immunologic treatment of cancer |
US10098566B2 (en) * | 2013-09-06 | 2018-10-16 | Covidien Lp | System and method for lung visualization using ultrasound |
US10026191B2 (en) | 2013-11-27 | 2018-07-17 | Analogic Corporation | Multi-imaging modality navigation system |
EA201691073A1 (en) | 2013-12-05 | 2016-12-30 | РФЕМБ ХОЛДИНГС, ЭлЭлСи | CANCER IMMUNOTHERAPY USING RADIO-FREQUENCY ELECTRICAL BREAKDOWN MEMBRANE (RF-EMB) |
ES2717444T3 (en) | 2014-02-28 | 2019-06-21 | 3Dbiopsy Inc | Needle biopsy system |
EP3182875B1 (en) * | 2014-08-23 | 2021-04-07 | Intuitive Surgical Operations, Inc. | Systems for display of pathological data in an image guided procedure |
EP2998932B1 (en) * | 2014-09-16 | 2021-01-27 | Esaote S.p.A. | Method and device for the acquisition of ultrasound images and for the fusion of such images with pre-acquired images |
WO2016123608A2 (en) | 2015-01-30 | 2016-08-04 | Rfemb Holdings, Llc | Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue |
CA2975926A1 (en) * | 2015-02-04 | 2016-08-11 | Rfemb Holdings, Llc | Radio-frequency electrical membrane breakdown for the treatment of benign prostatic hyperplasia |
CN104835169A (en) * | 2015-05-15 | 2015-08-12 | 三爱医疗科技(深圳)有限公司 | Prostate image integration method |
JP6438601B2 (en) * | 2015-06-26 | 2018-12-19 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Image guidance system |
CN109073725B (en) * | 2015-09-09 | 2021-02-19 | 皇家飞利浦有限公司 | System and method for planning and executing repetitive interventional procedures |
RU2746895C2 (en) * | 2015-12-24 | 2021-04-21 | Конинклейке Филипс Н.В. | Device for three-dimensional staining of biopsy tissue |
RU2610916C1 (en) * | 2016-01-29 | 2017-02-17 | Руслан Марсович Абдеев | Method for transrectal ultrasonic scanning in carrying out transurethral laser enucleation of prostate |
RU2611405C1 (en) * | 2016-02-15 | 2017-02-21 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) | Selection method of parts of prostatic gland for puncture in case of diagnosis of prostate cancer |
WO2017157974A1 (en) | 2016-03-16 | 2017-09-21 | Koninklijke Philips N.V. | System for assisting in performing an interventional procedure |
WO2018022979A1 (en) | 2016-07-28 | 2018-02-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Transperineal imaging-guided prostate needle placement |
WO2018060404A1 (en) * | 2016-09-29 | 2018-04-05 | Koninklijke Philips N.V. | System and method for planning and performing an interventional procedure based on the spatial relationships between identified points |
KR101931747B1 (en) | 2016-10-28 | 2019-03-13 | 삼성메디슨 주식회사 | Biopsy apparatus and method for operating the same |
JP6849462B2 (en) * | 2017-02-06 | 2021-03-24 | キヤノンメディカルシステムズ株式会社 | Medical information processing system and medical image processing device |
JP2020512166A (en) * | 2017-03-20 | 2020-04-23 | エグザクト イメージング インコーポレイテッド | Method and system for visually assisting an operator of an ultrasound system |
CN108814643A (en) * | 2018-04-04 | 2018-11-16 | 飞依诺科技(苏州)有限公司 | A kind of ultrasonic scanning method and apparatus |
US11107213B2 (en) * | 2018-12-28 | 2021-08-31 | Biosense Webster (Israel) Ltd. | Correcting medical scans |
US20200281561A1 (en) * | 2019-03-05 | 2020-09-10 | Ethos Medical, Inc. | Systems, Methods, and Devices for Instrument Guidance |
US11304683B2 (en) * | 2019-09-13 | 2022-04-19 | General Electric Company | Biopsy workflow using multimodal imaging |
JP7499135B2 (en) | 2020-09-28 | 2024-06-13 | オリンパス株式会社 | Ultrasound observation device, endoscope auxiliary device, operation method of ultrasound observation device, and operation program of ultrasound observation device |
US20220409167A1 (en) * | 2021-06-24 | 2022-12-29 | Biosense Webster (Israel) Ltd. | Visualization of 4d ultrasound maps |
CN114569146A (en) * | 2022-03-01 | 2022-06-03 | 西安大医集团股份有限公司 | Medical image processing method, medical image processing device, computer equipment and storage medium |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100208963A1 (en) * | 2006-11-27 | 2010-08-19 | Koninklijke Philips Electronics N. V. | System and method for fusing real-time ultrasound images with pre-acquired medical images |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058588A1 (en) * | 1997-06-23 | 1998-12-30 | Focus Surgery, Inc. | Methods and devices for providing acoustic hemostasis |
US6675037B1 (en) | 1999-09-29 | 2004-01-06 | Regents Of The University Of Minnesota | MRI-guided interventional mammary procedures |
JP4955172B2 (en) | 1999-12-15 | 2012-06-20 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Diagnostic imaging system with ultrasound probe |
EP1718194A4 (en) | 2004-01-20 | 2010-05-12 | Topspin Medical Israel Ltd | Mri probe for prostate imaging |
US20080132782A1 (en) | 2004-02-02 | 2008-06-05 | Rueckmann Bogdan Von | Combined MR-ultrasound (US) coil for prostate-, cevix- and rectum cancer imaging diagnostics |
US8932233B2 (en) | 2004-05-21 | 2015-01-13 | Devicor Medical Products, Inc. | MRI biopsy device |
US20060116576A1 (en) * | 2004-12-01 | 2006-06-01 | Scimed Life Systems, Inc. | System and use thereof to provide indication of proximity between catheter and location of interest in 3-D space |
US8788019B2 (en) * | 2005-02-28 | 2014-07-22 | Robarts Research Institute | System and method for performing a biopsy of a target volume and a computing device for planning the same |
US8548562B2 (en) * | 2006-04-04 | 2013-10-01 | John Trachtenberg | System and method of guided treatment within malignant prostate tissue |
KR100971417B1 (en) * | 2006-10-17 | 2010-07-21 | 주식회사 메디슨 | Ultrasound system for displaying neddle for medical treatment on compound image of ultrasound image and external medical image |
US20080119725A1 (en) * | 2006-11-20 | 2008-05-22 | General Electric Company | Systems and Methods for Visual Verification of CT Registration and Feedback |
US20080161687A1 (en) * | 2006-12-29 | 2008-07-03 | Suri Jasjit S | Repeat biopsy system |
US8885897B2 (en) | 2007-10-26 | 2014-11-11 | Koninklijke Philips N.V. | Closed loop registration control for multi-modality soft tissue imaging |
EP2223150A1 (en) | 2007-11-14 | 2010-09-01 | Koninklijke Philips Electronics N.V. | System and method for automatic calibration of tracked ultrasound |
RU2510699C2 (en) | 2008-06-20 | 2014-04-10 | Конинклейке Филипс Электроникс, Н.В. | Method and system for biopsy |
CN100586379C (en) * | 2008-07-04 | 2010-02-03 | 浙江大学 | Computer simulation scaling biopsy method and apparatus |
-
2010
- 2010-05-14 CN CN201080030085.8A patent/CN102481115B/en active Active
- 2010-05-14 BR BRPI1009004A patent/BRPI1009004A2/en not_active Application Discontinuation
- 2010-05-14 US US13/321,836 patent/US10980508B2/en active Active
- 2010-05-14 EP EP10727139.7A patent/EP2437661B1/en active Active
- 2010-05-14 JP JP2012513693A patent/JP5587993B2/en active Active
- 2010-05-14 WO PCT/IB2010/052152 patent/WO2010140075A2/en active Application Filing
- 2010-05-14 RU RU2011154203/14A patent/RU2558521C2/en active
-
2021
- 2021-02-16 US US17/176,218 patent/US20210161507A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100208963A1 (en) * | 2006-11-27 | 2010-08-19 | Koninklijke Philips Electronics N. V. | System and method for fusing real-time ultrasound images with pre-acquired medical images |
Non-Patent Citations (2)
Title |
---|
"MRI/TRUS data fusion for prostate brachytherapy. Preliminary results" by C.Reynier et al. Medical Physics. 31 (6) 2004 (Year: 2004) * |
"Real time MRI-ultrasound image guided stereotactic prostate biopsy" by I. Kaplan et al. Magnetic Resonance Imaging. 20 (2002) pp.295-299 (Year: 2002) * |
Also Published As
Publication number | Publication date |
---|---|
JP2012528649A (en) | 2012-11-15 |
WO2010140075A2 (en) | 2010-12-09 |
WO2010140075A3 (en) | 2011-01-27 |
US10980508B2 (en) | 2021-04-20 |
BRPI1009004A2 (en) | 2016-03-08 |
RU2558521C2 (en) | 2015-08-10 |
CN102481115B (en) | 2014-11-26 |
US20120071749A1 (en) | 2012-03-22 |
JP5587993B2 (en) | 2014-09-10 |
RU2011154203A (en) | 2013-07-20 |
EP2437661B1 (en) | 2021-04-07 |
EP2437661A2 (en) | 2012-04-11 |
CN102481115A (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210161507A1 (en) | System and method for integrated biopsy and therapy | |
US20200085412A1 (en) | System and method for using medical image fusion | |
US11950967B2 (en) | System and method for planning and performing a repeat interventional procedure | |
US20140073907A1 (en) | System and method for image guided medical procedures | |
US8548562B2 (en) | System and method of guided treatment within malignant prostate tissue | |
RU2510699C2 (en) | Method and system for biopsy | |
US7831293B2 (en) | Method of defining a biological target for treatment | |
US10166078B2 (en) | System and method for mapping navigation space to patient space in a medical procedure | |
Sridhar et al. | Image-guided robotic interventions for prostate cancer | |
EP1542591A2 (en) | Methods and systems for localizing a medical imaging probe and for spatial registration and mapping of a biopsy needle during a tissue biopsy | |
WO2014031531A1 (en) | System and method for image guided medical procedures | |
US20210275155A1 (en) | Image guidance system | |
Rapetti et al. | Virtual reality navigation system for prostate biopsy | |
Kettenbach et al. | Computer-based imaging and interventional MRI: applications for neurosurgery | |
De Silva et al. | Evaluating the utility of intraprocedural 3D TRUS image information in guiding registration for displacement compensation during prostate biopsy | |
Coleman et al. | Advances in imaging for urologic procedures | |
Alameddine et al. | Image Fusion Principles: Theory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |